Henan Taloph Pharmaceutical Stock Co.,Ltd Sustainability Profile
Henan Taloph Pharmaceutical Stock Co., Ltd., commonly referred to as Taloph, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across various regions in China, Taloph is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of APIs and formulations that cater to both domestic and international markets. Taloph's unique approach to research and development has positioned it as a trusted partner in the pharmaceutical sector, contributing to its notable achievements and solid market standing.
DitchCarbon Score
How does Henan Taloph Pharmaceutical Stock Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Henan Taloph Pharmaceutical Stock Co.,Ltd's score of 22 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Henan Taloph Pharmaceutical Stock Co.,Ltd's reported carbon emissions
Henan Taloph Pharmaceutical Stock Co., Ltd, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company, suggesting a lack of formal commitments to address carbon emissions at this time. As the company does not inherit emissions data from a parent organisation, it operates independently regarding its climate impact reporting. Without available data or commitments, it is unclear how Henan Taloph Pharmaceutical Stock Co., Ltd plans to engage with climate initiatives or reduce its carbon footprint in the pharmaceutical industry context.
How Carbon Intensive is Henan Taloph Pharmaceutical Stock Co.,Ltd's Industry?
How Carbon Intensive is Henan Taloph Pharmaceutical Stock Co.,Ltd's Location?
Henan Taloph Pharmaceutical Stock Co.,Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Henan Taloph Pharmaceutical Stock Co.,Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
